vs
奎斯特诊断(IMDX)与Marathon Bancorp, Inc.(MBBC)财务数据对比。点击上方公司名可切换其他公司
Marathon Bancorp, Inc.的季度营收约是奎斯特诊断的2.0倍($2.2M vs $1.1M),Marathon Bancorp, Inc.净利率更高(22.3% vs -2015.4%,领先2037.7%),Marathon Bancorp, Inc.同比增速更快(41.7% vs -23.4%),Marathon Bancorp, Inc.自由现金流更多($1.4M vs $-7.0M),过去两年奎斯特诊断的营收复合增速更高(154.4% vs 20.3%)
奎斯特诊断公司是一家美国临床检验企业,跻身财富500强,业务覆盖美国本土,以及波多黎各、墨西哥、巴西等地区,同时与全球多家医院和诊所保持合作关系,是行业内颇具影响力的医疗诊断服务提供商。
Marathon Bancorp, Inc.是总部位于美国马里兰州的金融控股公司,旗下运营社区银行子公司,面向马里兰州本地个人及中小企业客户提供存款账户、消费贷款、商业抵押贷款、小微企业融资等全品类零售及商业银行服务。
IMDX vs MBBC — 直观对比
营收规模更大
MBBC
是对方的2.0倍
$1.1M
营收增速更快
MBBC
高出65.0%
-23.4%
净利率更高
MBBC
高出2037.7%
-2015.4%
自由现金流更多
MBBC
多$8.4M
$-7.0M
两年增速更快
IMDX
近两年复合增速
20.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.1M | $2.2M |
| 净利润 | $-23.0M | $501.4K |
| 毛利率 | 42.5% | — |
| 营业利润率 | -2057.5% | 26.2% |
| 净利率 | -2015.4% | 22.3% |
| 营收同比 | -23.4% | 41.7% |
| 净利润同比 | 31.5% | 880.7% |
| 每股收益(稀释后) | $-0.75 | $0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IMDX
MBBC
| Q4 25 | $1.1M | $2.2M | ||
| Q3 25 | $260.0K | $2.1M | ||
| Q2 25 | $518.0K | $1.9M | ||
| Q1 25 | $2.1M | $1.7M | ||
| Q4 24 | $1.5M | $1.6M | ||
| Q3 24 | $115.0K | $1.6M | ||
| Q2 24 | $104.0K | $1.6M | ||
| Q1 24 | $176.0K | $1.6M |
净利润
IMDX
MBBC
| Q4 25 | $-23.0M | $501.4K | ||
| Q3 25 | $-10.9M | $444.3K | ||
| Q2 25 | $-9.7M | $-332.0K | ||
| Q1 25 | $-6.7M | $148.4K | ||
| Q4 24 | $-33.5M | $51.1K | ||
| Q3 24 | $-13.5M | $174.9K | ||
| Q2 24 | $-4.5M | $85.8K | ||
| Q1 24 | $-9.1M | $-631.1K |
毛利率
IMDX
MBBC
| Q4 25 | 42.5% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 67.6% | — | ||
| Q1 25 | 62.0% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 43.5% | — | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 25.6% | — |
营业利润率
IMDX
MBBC
| Q4 25 | -2057.5% | 26.2% | ||
| Q3 25 | -4249.2% | 25.5% | ||
| Q2 25 | -1900.0% | -25.7% | ||
| Q1 25 | -318.0% | 11.6% | ||
| Q4 24 | -2262.9% | 3.3% | ||
| Q3 24 | -11752.2% | 13.4% | ||
| Q2 24 | -4453.8% | 4.1% | ||
| Q1 24 | -5265.3% | -53.7% |
净利率
IMDX
MBBC
| Q4 25 | -2015.4% | 22.3% | ||
| Q3 25 | -4174.6% | 20.7% | ||
| Q2 25 | -1880.7% | -18.9% | ||
| Q1 25 | -312.0% | 8.9% | ||
| Q4 24 | -2255.1% | 3.2% | ||
| Q3 24 | -11733.0% | 10.8% | ||
| Q2 24 | -4355.8% | 6.2% | ||
| Q1 24 | -5186.9% | -40.7% |
每股收益(稀释后)
IMDX
MBBC
| Q4 25 | $-0.75 | $0.19 | ||
| Q3 25 | $-0.34 | $0.17 | ||
| Q2 25 | $-0.30 | $-0.13 | ||
| Q1 25 | $-0.26 | $0.07 | ||
| Q4 24 | $-2.19 | $0.02 | ||
| Q3 24 | $-0.98 | $0.06 | ||
| Q2 24 | $-0.36 | $0.07 | ||
| Q1 24 | $-1.13 | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-31.5M | $46.9M |
| 总资产 | $25.8M | $248.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IMDX
MBBC
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | — | ||
| Q2 25 | $24.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $5.6M | — |
股东权益
IMDX
MBBC
| Q4 25 | $-31.5M | $46.9M | ||
| Q3 25 | $-9.2M | $46.3M | ||
| Q2 25 | $1.1M | $45.7M | ||
| Q1 25 | $10.2M | $32.0M | ||
| Q4 24 | $-12.3M | $31.7M | ||
| Q3 24 | $9.7M | $31.6M | ||
| Q2 24 | $22.7M | $31.3M | ||
| Q1 24 | $11.6M | $31.4M |
总资产
IMDX
MBBC
| Q4 25 | $25.8M | $248.0M | ||
| Q3 25 | $43.9M | $246.0M | ||
| Q2 25 | $50.5M | $238.8M | ||
| Q1 25 | $60.4M | $236.8M | ||
| Q4 24 | $35.1M | $217.9M | ||
| Q3 24 | $70.2M | $216.5M | ||
| Q2 24 | $74.7M | $219.3M | ||
| Q1 24 | $71.0M | $225.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-5.5M | $1.4M |
| 自由现金流经营现金流 - 资本支出 | $-7.0M | $1.4M |
| 自由现金流率自由现金流/营收 | -616.7% | 62.3% |
| 资本支出强度资本支出/营收 | 129.9% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 2.82× |
| 过去12个月自由现金流最近4个季度 | $-25.4M | $3.9M |
8季度趋势,按日历期对齐
经营现金流
IMDX
MBBC
| Q4 25 | $-5.5M | $1.4M | ||
| Q3 25 | $-4.5M | $464.0K | ||
| Q2 25 | $-6.3M | $1.4M | ||
| Q1 25 | $-5.9M | $849.0K | ||
| Q4 24 | $-5.4M | $113.6K | ||
| Q3 24 | $-5.5M | $945.2K | ||
| Q2 24 | $-6.0M | $416.6K | ||
| Q1 24 | $-3.8M | $-802.1K |
自由现金流
IMDX
MBBC
| Q4 25 | $-7.0M | $1.4M | ||
| Q3 25 | $-5.6M | $456.6K | ||
| Q2 25 | $-6.6M | $1.3M | ||
| Q1 25 | $-6.2M | $773.2K | ||
| Q4 24 | $-5.6M | $105.0K | ||
| Q3 24 | $-5.6M | $921.6K | ||
| Q2 24 | $-6.2M | $-1.8M | ||
| Q1 24 | $-3.9M | $-1.1M |
自由现金流率
IMDX
MBBC
| Q4 25 | -616.7% | 62.3% | ||
| Q3 25 | -2135.4% | 21.3% | ||
| Q2 25 | -1279.5% | 66.0% | ||
| Q1 25 | -288.4% | 46.3% | ||
| Q4 24 | -374.5% | 6.6% | ||
| Q3 24 | -4884.3% | 57.1% | ||
| Q2 24 | -5931.7% | -118.5% | ||
| Q1 24 | -2189.8% | -67.9% |
资本支出强度
IMDX
MBBC
| Q4 25 | 129.9% | 0.6% | ||
| Q3 25 | 403.8% | 0.3% | ||
| Q2 25 | 67.4% | 9.3% | ||
| Q1 25 | 14.4% | 4.5% | ||
| Q4 24 | 14.4% | 0.5% | ||
| Q3 24 | 75.7% | 1.5% | ||
| Q2 24 | 183.7% | 145.2% | ||
| Q1 24 | 13.6% | 16.2% |
现金转化率
IMDX
MBBC
| Q4 25 | — | 2.82× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.72× | ||
| Q4 24 | — | 2.22× | ||
| Q3 24 | — | 5.40× | ||
| Q2 24 | — | 4.85× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图